Advanced Search

column
Research Status and Progress on Treatment of Advanced Gastric Cancer
DONG Caixia, YUAN Ying
2022, 49(11): 1095-1102. DOI: 10.3971/j.issn.1000-8578.2022.22.0596
Abstract FullText HTML PDF
Research Progress of Diagnosis and Treatment of Glioblastoma
CHEN Qianxue
2022, 49(11): 1103-1106. DOI: 10.3971/j.issn.1000-8578.2022.22.0090
Abstract FullText HTML PDF
Progress on Correlation Between Type 2 Diabetes Mellitus and Malignant Tumors
ZHOU Han, SHENG Deqiao
2022, 49(11): 1107-1111. DOI: 10.3971/j.issn.1000-8578.2022.21.1324
Abstract FullText HTML PDF
Expression of ITGAV in Non-small Cell Lung Cancer and Its Relationship with Radioresistance
TANG Yuanhui, ZHU Shengming, CHAI Jingjing, HAN Jiahui, TIAN Chao, DENG Xingzhou, DUAN Qiwen
2022, 49(11): 1112-1118. DOI: 10.3971/j.issn.1000-8578.2022.22.0177
Abstract FullText HTML PDF
Effects of Cholesterol-lowering Agents on Proliferation, Invasion and Neutrophil Extracellular Trap Formation in Liver Cancer Cells
TANG Qiqi, LI Yan, SUN Guowei, LIANG Beibei, ZHAO Jian
2022, 49(11): 1119-1125. DOI: 10.3971/j.issn.1000-8578.2022.22.0280
Abstract FullText HTML PDF
Effects and Mechanisms of Combined Application of Molecular Targeted Drugs on Proliferation of Hepatocellular Carcinoma SK-Hep-1 Cells
ZHU Xiaoxia, JIA Yuqi, LIU Chang, GONG Tao, LI Gaopeng, ZHANG Hongwei, YU Baofeng
2022, 49(11): 1126-1133. DOI: 10.3971/j.issn.1000-8578.2022.22.0157
Abstract FullText HTML PDF
Jinfukang Inhibits Lung Cancer Metastasis by Regulating Immune Senescence
YAO Wang, QUE Zujun, YAO Jialiang, YU Pan, LUO Bin, TIAN Jianhui
2022, 49(11): 1134-1138. DOI: 10.3971/j.issn.1000-8578.2022.21.1474
Abstract FullText HTML PDF
Safety and Efficacy of Irreversible Electroporation Combined with Neoadjuvant Chemotherapy for Locally Advanced Pancreatic Cancer: A Meta-analysis
ZHAO Baoyin, LIANG Zhaojun, ZHANG Lixia, CHEN Shun, JIA Dong, WU Zhaohui, LI Bin, WANG Junke, MA Jun, YU Xiaohui
2022, 49(11): 1139-1145. DOI: 10.3971/j.issn.1000-8578.2022.22.0367
Abstract FullText HTML PDF
Expression and Clinical Significance of TM9SF3 in Lung Adenocarcinoma
YU Hualin, XU Yinghua, WANG Mingwei, LI Shuguang, ZHANG Wenwen, YANG Jinsong, LI Wei
2022, 49(11): 1146-1152. DOI: 10.3971/j.issn.1000-8578.2022.22.0212
Abstract FullText HTML PDF
Prognostic Factors in Patients with Advanced Lung Adenocarcinoma Treated with Icotinib
ZHANG Hongbin, ZHU Lingling, XIE Jiong, CAI Hongmei, JI Qiaoxia, LIANG Xiangcun, LI Hua, WANG Yuan, ZHAO Min
2022, 49(11): 1153-1158. DOI: 10.3971/j.issn.1000-8578.2022.22.0174
Abstract FullText HTML PDF
Expression of YBX1 and FOXA1 in Gastric Cancer and Their Clinicopathological Significance
PEI Zhenghao, ZHANG Hu, WANG Jun, HAO Yang
2022, 49(11): 1159-1164. DOI: 10.3971/j.issn.1000-8578.2022.22.0189
Abstract FullText HTML PDF
Clinicopathological Significance of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma
PENG Hui, ZHANG Zhifa, WU Yingjun, ZHANG Xiaohan, ZHU Xianqiang, QIN Haili
2022, 49(11): 1165-1167. DOI: 10.3971/j.issn.1000-8578.2022.22.0312
Abstract FullText HTML PDF
Data Mining for Adverse Events Signals of Acalabrutinib Based on FAERS Database
LIANG Cuilyu, ZHANG Yin, CHEN Qiying
2022, 49(11): 1168-1174. DOI: 10.3971/j.issn.1000-8578.2022.22.0183
Abstract FullText HTML PDF
Biological Mechanism of Pyroptosis and Its Research Progress in Breast Cancer
DOU He, MA Shuang, ZHU Yue, LIU Yuqi, XIAO Min
2022, 49(11): 1175-1179. DOI: 10.3971/j.issn.1000-8578.2022.22.0485
Abstract FullText HTML PDF
Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
HONG Chenchen, YAO Feng
2022, 49(11): 1180-1183. DOI: 10.3971/j.issn.1000-8578.2022.22.0332
Abstract FullText HTML PDF
Research Progress on Effects of Gut Microbiome on Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer
WANG Yijie, ZHANG Gangwei, XU Chao, YAO Qinghua
2022, 49(11): 1184-1189. DOI: 10.3971/j.issn.1000-8578.2022.22.0429
Abstract FullText HTML PDF
Epidemiological Study of New Cases of Peritoneal Metastases
YANG Rui, SU Yandong, MA Ru, AN Songlin, LIN Yulin, LI Yan
2022, 49(11): 1190-1194. DOI: 10.3971/j.issn.1000-8578.2022.22.0270
Abstract FullText HTML PDF
Non-alcoholic Fatty Liver Disease Affect Efficacy of Immune Checkpoint Inhibitors for Patients with Hepatocellular Carcinoma: Manifestations and Mechanisms
YUAN Ye, PENG Hui, TIAN De'an
2022, 49(11): 1195-1201. DOI: 10.3971/j.issn.1000-8578.2022.22.0562
Abstract FullText HTML PDF
Cutaneous Squamous-cell Carcinoma During Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Report and Literature Review
LI Huiting, CAI Mei, BI Hui
2022, 49(11): 1202-1204. DOI: 10.3971/j.issn.1000-8578.2022.22.0258
Abstract FullText HTML PDF
Global Incidence of Cancer Among People Under 50 Years Old Is Rising, etc.
2022, 49(11): 1205-1206. DOI: 10.3971/j.issn.1000-8578.2022.11.0001
Abstract FullText HTML PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：